Trial finds vitamin D supplements don’t reduce COVID severity but could reduce long COVID risk

In a large, randomized trial, researchers at Mass General Brigham found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes. Results of the study are published in The Journal of Nutrition.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup